A new immune structure found in liver tumors could improve treatment for liver cancer patients. These structures are linked ...

In the quest to enhance the efficacy of chimeric antigen receptor T (CAR-T) cell therapy against hepatocellular carcinoma ...

Chemoembolization (TACE): Delivers chemotherapy directly into the liver Thermal ablation: Utilizing heat to destroy cancer cells Get Vaccinated: Protect yourself with the hepatitis B vaccine ...

Carisma Therapeutics (CARM) announced the upcoming presentation of new pre-clinical data on its anti-GPC3 in vivo chimeric antigen receptor ...

Carisma Therapeutics Inc. (Nasdaq: CARM) ("Carisma" or the "Company"), a clinical-stage biopharmaceutical company focused on discovering and developing innovative immunotherapies, today announced the ...

Hepatocellular carcinoma (HCC) is one of the most fatal malignancies. Epigenetic mechanisms have revealed that noncoding RNAs ...

前言一年一度的肿瘤领域盛会——2024年欧洲肿瘤内科学会亚洲年会（ESMO ...

International perspectives on when to utilize transarterial radioembolization to increase the likelihood of curative outcomes ...

A risk stratification algorithm may be able to predict which patients with advanced chronic liver disease are at risk of ...

The following is a summary of the study "Clinical study on conversion therapy of hepatocellular carcinoma - summary and ...

A newly described stage of a lymph node-like structure seen in liver tumors after presurgical immunotherapy may be vital to ...

Early detection of hepatocellular carcinoma (HCC) is crucial for improving survival in patients with chronic hepatitis.